Tumor heterogeneity: morphological, molecular and clinical implications.
about
Landscape phage ligands for PC3 prostate carcinoma cellsPrognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast.Intratumoral Heterogeneity of Subcutaneous Nodules in a Never-Smoker Woman of Lung Squamous Cell Carcinoma Detected on 18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography: A Case Report.Determination of regional lymph node status using (18)F-FDG PET/CT parameters in oesophageal cancer patients: comparison of SUV, volumetric parameters and intratumoral heterogeneity.
P2860
Tumor heterogeneity: morphological, molecular and clinical implications.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Tumor heterogeneity: morphological, molecular and clinical implications.
@ast
Tumor heterogeneity: morphological, molecular and clinical implications.
@en
Tumor heterogeneity: morphological, molecular and clinical implications.
@nl
type
label
Tumor heterogeneity: morphological, molecular and clinical implications.
@ast
Tumor heterogeneity: morphological, molecular and clinical implications.
@en
Tumor heterogeneity: morphological, molecular and clinical implications.
@nl
prefLabel
Tumor heterogeneity: morphological, molecular and clinical implications.
@ast
Tumor heterogeneity: morphological, molecular and clinical implications.
@en
Tumor heterogeneity: morphological, molecular and clinical implications.
@nl
P2093
P356
P1476
Tumor heterogeneity: morphological, molecular and clinical implications.
@en
P2093
Lleonart ME
Martin-Duque P
Ramon y Cajal S
Sanchez-Prieto R
P304
P356
10.14670/HH-15.881
P577
2000-07-01T00:00:00Z